These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11474789)

  • 1. Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    Pharm Res; 2001 Jun; 18(6):838-45. PubMed ID: 11474789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    J Pharm Sci; 2002 Jan; 91(1):41-52. PubMed ID: 11782896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: a population pharmacokinetic model.
    Jauregizar N; Quintana A; Suarez E; Raczka E; de la Fuente L; Calvo R
    Gerontology; 2003; 49(4):205-14. PubMed ID: 12792155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model.
    Ortega F; Quintana A; Suárez E; Lukas JC; Jauregizar N; de la Fuente L; Lucero ML; Gonzalo A; Orjales A; Calvo R
    Pharm Res; 2005 Nov; 22(11):1769-82. PubMed ID: 16158214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of elevated α
    Ebihara T; Shimizu H; Yamamoto M; Higuchi T; Jinno F; Tagawa Y
    Xenobiotica; 2019 May; 49(5):584-590. PubMed ID: 29790816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Cooper M; Sologuren A; Valiente R; Smith J
    Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-acid glycoprotein directly affects the pharmacokinetics and the analgesic effect of methadone in the rat beyond protein binding.
    Rodriguez M; Ortega I; Soengas I; Leal N; Suarez E; Calvo R; Lukas JC
    J Pharm Sci; 2004 Nov; 93(11):2836-50. PubMed ID: 15452846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lerisetron. F 0930, F 0930RS.
    Drugs R D; 1999 Oct; 2(4):245-6. PubMed ID: 10659400
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiemetic effects of Lerisetron in radiation-induced emesis in the dog.
    Gomez-de-Segura IA; Grande AG; De Miguel E
    Acta Oncol; 1998; 37(7-8):759-63. PubMed ID: 10050999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
    Ozaki A; Fujishima Y; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.
    Man WH; Wilting I; Heerdink ER; Hugenholtz GWK; Bognár T; Ten Berg MJ; van Solinge WW; Egberts TACG; van Maarseveen EM
    Clin Pharmacokinet; 2019 Aug; 58(8):1069-1075. PubMed ID: 31111332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
    Oie S; Fiori F; Chiang J
    J Pharmacol Exp Ther; 1987 Jun; 241(3):934-8. PubMed ID: 3598910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional group interactions of a 5-HT3R antagonist.
    Venkataraman P; Joshi P; Venkatachalan SP; Muthalagi M; Parihar HS; Kirschbaum KS; Schulte MK
    BMC Biochem; 2002 Jun; 3():16. PubMed ID: 12079499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alpha(1)-acid glycoprotein on the pharmacokinetics of tamsulosin in rats treated with turpentine oil.
    Matsushima H; Watanabe T; Higuchi S
    J Pharm Sci; 2000 Apr; 89(4):490-8. PubMed ID: 10737910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
    Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
    Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.
    Rodriguez M; Carlos MA; Ortega I; Suarez E; Calvo R; Lukas JC
    Pharm Res; 2002 Jun; 19(6):858-67. PubMed ID: 12134958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.